Near-Infrared Optical Imaging of Integrin αvβ3 in Human Tumor Xenografts
暂无分享,去创建一个
Eva M. Sevick-Muraca | Shi Ke | Wei Wang | Juri G. Gelovani | Qingping Wu | James L. Abbruzzese | C. Charnsangavej | E. Sevick-Muraca | J. Abbruzzese | J. Gelovani | S. Ke | Chun Li | Mikhail Gurfinkel | Chun Li | Wei Wang | Chusilp Charnsangavej | M. Gurfinkel | Qingping Wu
[1] A. Shilkaitis,et al. Beta3 integrin expression in melanoma predicts subsequent metastasis. , 1996, The Journal of surgical research.
[2] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[3] David A. Cheresh,et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.
[4] M. Schwaiger,et al. Synthesis and biological evaluation of a 99mTc-labelled cyclic RGD peptide for imaging the αvβ3 expression , 2004, Nuklearmedizin.
[5] A B Thompson,et al. Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: phantom studies. , 2004, Journal of biomedical optics.
[6] D. Cheresh. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Brugge,et al. Integrins and signal transduction pathways: the road taken. , 1995, Science.
[8] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[9] Ryan Park,et al. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. , 2004, Bioconjugate chemistry.
[10] A. Halpern,et al. A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma , 1996, Annals of Internal Medicine.
[11] E. Sevick-Muraca,et al. Near-Infrared Fluorescence Optical Imaging and Tomography , 2004, Disease markers.
[12] Daniel L. Farkas,et al. Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies , 1995, Cancer Immunology, Immunotherapy.
[13] R. Taillefer,et al. Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis. , 2003, Archives of internal medicine.
[14] Chun Li,et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. , 2003, Cancer research.
[15] D. Cheresh,et al. Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. , 1992, The Journal of clinical investigation.
[16] D. Cheresh,et al. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.
[17] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[18] Christoph Ballestrem,et al. Marching at the front and dragging behind , 2001, The Journal of cell biology.
[19] Robert E. Lenkinski,et al. In vivo near-infrared fluorescence imaging of osteoblastic activity , 2001, Nature Biotechnology.
[20] Horst Kessler,et al. Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting , 1999 .
[21] D. Ruiter,et al. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice , 2007, International journal of cancer.
[22] M Schwaiger,et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] J. Bading,et al. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. , 2004, Nuclear medicine and biology.
[24] E Ruoslahti,et al. New perspectives in cell adhesion: RGD and integrins. , 1987, Science.
[25] J. Schneider-Mergener,et al. Cyanine Dye Labeled Vasoactive Intestinal Peptide and Somatostatin Analog for Optical Detection of Gastroenteropancreatic Tumors , 2000, Annals of the New York Academy of Sciences.
[26] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[27] F. Sarkar,et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.
[28] Milind Rajopadhye,et al. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. , 2002, Cancer research.
[29] M. Schwaiger,et al. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. , 2004, Bioconjugate chemistry.
[30] R. Weissleder,et al. Charge-coupled-device based scanner for tomography of fluorescent near-infrared probes in turbid media. , 2002, Medical physics.
[31] S. Achilefu,et al. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.
[32] Sibylle Ziegler,et al. Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .
[33] H. Bergh,et al. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.